Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist
-
March 26, 2026
-
2 min
March 26, 2026
March 26, 2026
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.